Literature DB >> 4858165

Successful treatment of galactorrhoea and amenorrhoea and subsequent restoration of ovarian function by a new ergot alkaloid 2-brom-alpha-ergocryptine.

R Rolland, L A Schellekens, R M Lequin.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4858165     DOI: 10.1111/j.1365-2265.1974.tb01791.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


× No keyword cloud information.
  8 in total

1.  An abnormality of oestrogen feedback in amenorrhoea-galactorrhoea.

Authors:  M R Glass; R W Shaw; W R Butt; R L Edwards; D R London
Journal:  Br Med J       Date:  1975-08-02

2.  Hypothalamic-pituitary-ovarian function in hyperprolactinemic women.

Authors:  P Travaglini; B Ambrosi; P Beck-Peccoz; R Elli; M Rondena; R Bara; G Weber
Journal:  J Endocrinol Invest       Date:  1978-01       Impact factor: 4.256

Review 3.  Use of bromocriptine in the inhibition of puerperal lactation.

Authors:  R Rolland
Journal:  Drugs       Date:  1979-05       Impact factor: 9.546

4.  Serum LH increase after estradiol and progesterone administration in hyperprolactinemic women.

Authors:  P Travaglini; R Elli; B Ambrosi; M Ballabio; P Moriondo; G Faglia
Journal:  J Endocrinol Invest       Date:  1979 Oct-Dec       Impact factor: 4.256

5.  Comparison between tamoxifen and clomiphene therapy in women with anovulation.

Authors:  I Gerhard; B Runnebaum
Journal:  Arch Gynecol       Date:  1979

6.  Treatment of galactorrhea-amenorrhea syndrome with 2-Br-alpha-ergocryptin (CB 154). Clinical response and pattern of pituitary and steriod hormones before and during therapy.

Authors:  H J Künzig; W Geiger; K D Schulz; K H Lose
Journal:  Arch Gynakol       Date:  1975

Review 7.  Bromocriptine in the treatment of hypogonadism and male impotence.

Authors:  C M March
Journal:  Drugs       Date:  1979-05       Impact factor: 9.546

8.  Bromocriptine therapy in acromegaly. A long-term review of 35 cases.

Authors:  Y Sachdev; K Gopal; V K Garg
Journal:  Postgrad Med J       Date:  1981-04       Impact factor: 2.401

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.